Cardiovascular Heart Disease: From Molecular Mechanisms to Lifestyle Medicine

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...
Jezebel

Japan Is Facing a Strange Crisis of Deadly Bear Attacks

There were about as many deadly bear attacks in Japan in just 2025 as there are in the United States in the average decade.
JezebelOpinion

Trump Casually Mentions That We’re Apparently Bombing Venezuela Now

Trump mentioned the first U.S. strike on Venezuelan soil in a radio interview as if it wasn't even important news.

Arrowhead Pharmaceuticals Announces Health Canada Approval of REDEMPLO™ (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLO™ (plozasiran), a small interfering RNA (siRNA) medicine, ...

Best home gym equipment 2026: kick-start your routine and skip the pricey gym membership

If the thought of overpaying for an expensive gym makes you sweat, why not invest in home gym equipment instead? Before you ...

Erectin 2026: Clinical Research, Absorption Technology, and Consumer Considerations Exposed in New Category Analysis

A comprehensive industry examination reveals what manufacturer disclosures, clinical study documentation, and delivery system ...
Le Lézard

Arrowhead Pharmaceuticals Announces Health Canada Approval of REDEMPLOtm (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)

Arrowhead Pharmaceuticals, Inc. today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLOtm (plozasiran), a small interfering RNA (siRNA) medicine, as an adjunct ...